Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens
Clinical trial NCT05219669 · COMPLETED
Trial details
- NCT number
- NCT05219669
- Sponsor
- Opiant Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2021-11-19
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.